Evidence map›Paper›PMID 32708409›Full record

ArticlePharmaceutics2020

Y-Site Physical Compatibility of Numeta G13E with Drugs Frequently Used at Neonatal Intensive Care.

Katerina Nezvalova-Henriksen, Niklas Nilsson, Camilla Tomine Østerberg, Vigdis Staven Berge, Ingunn Tho

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Katerina Nezvalova-HenriksenOslo Hospital Pharmacy, Rikshospitalet/Ullevål, Hospital Pharmacy Enterprise, South Eastern Norway, 0050 Oslo, Norway.
Niklas NilssonOslo Hospital Pharmacy, Rikshospitalet/Ullevål, Hospital Pharmacy Enterprise, South Eastern Norway, 0050 Oslo, Norway.
Camilla Tomine ØsterbergDepartment of Pharmacy, University of Oslo, 0316 Oslo, Norway.
Vigdis Staven BergeOslo Hospital Pharmacy, Rikshospitalet/Ullevål, Hospital Pharmacy Enterprise, South Eastern Norway, 0050 Oslo, Norway.
Ingunn ThoDepartment of Pharmacy, University of Oslo, 0316 Oslo, Norway.ORCID 0000-0003-4241-4183
University of Oslo · NO

Funding

Helse Sør-Øst RHF 2018096
6 · The paper itself

Abstract

Preterm neonates require parenteral nutrition (PN) in addition to intravenous drug therapy. Due to limited venous access, drugs are often co-administered with PN via the same lumen. If incompatible, precipitation and emulsion destabilization may occur with the consequent risk of embolism and hyper-immune reactions. Information on intravenous compatibility is scarce. Our aim was to analyse the compatibility of Numeta G13E with paracetamol, vancomycin and fentanyl because of the frequency of their use. A panel of methods was chosen to assess precipitation (sub-visual particle counting, turbidity measurement, Tyndall beam effect and pH measurement) and emulsion destabilization (mean droplet diameter measurement and sub-visual counting of oil droplets, followed by estimation of PFAT5 (percentage of fat residing in globules larger than 5 µm) and pH measurement). Samples in clinically relevant mixing ratios were tested immediately and after 4 h. All samples of drugs mixed with Numeta G13E were compared to unmixed controls. None of the tested drugs precipitated in contact with Numeta G13E, and we did not see any sign of emulsion destabilization when clinically relevant mixing ratios were applied. These results are reassuring. However, when contact time exceeds the established norm, caution in the form of filter utilisation and close inspection is advised.

Indexed as

clinical pharmacyemulsion stabilityfentanylpaediatricsparacetamolparenteral nutrition PNpatient safetyPFAT5precipitationvancomycin

Identifiers

PMID32708409
PMCPMC7408039
OpenAlexW3042543935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.